 Based on our previous four coverages of QuidelOrtho, we compiled our views and determined whether its fundamentals had changed or remained, based on its latest earnings results. Compared to competitors, we believe Quidel is less competitive than its larger peers such as Roche and Abbott, but believe its smaller size presents a longer runway for growth. 